Related Experiment Video
Updated: Jun 19, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
[Correlation between central corneal thickness and axial length in patients with glaucoma and normal eyes]
Paula Resende Aquino de Assis Pereira Mello1, Sérgio Henrique Sampaio Meirelles, Haroldo Vieira de Moraes Júnior
1Departamento de Oftalmologia Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. paula.raap@gmail.com
Purpose:
To evaluate and to correlate the central corneal thickness with the ocular axial length in patients with primary open-angle glaucoma, primary angle-closure glaucoma and individuals with normal eyes.
Methods:
The sample was composed of 94 patients' eyes, divided into three groups constituted of 33 eyes of 33 primary open-angle glaucoma patients, 30 eyes of 30 primary angle-closure glaucoma patients and 31 normal eyes of 31 individuals. The central corneal thickness and the axial length were measured by ultrasonic pachymeter and biometry by A-scan ultrasound, respectively.
Results:
The results showed a mean of 535.1 mm central corneal thickness in primary angle-closure glaucoma group, 520.6 mm in primary open-angle glaucoma group and 519.2 mm in normal eyes (p=0.18). The ocular axial length on primary angle-closure glaucoma group was 22.16 mm and on primary open-angle glaucoma and normal eyes group was 22.68 mm and 22.64 mm, respectively (p=0.13). There was no significant correlation between corneal thickness and axial length in the primary angle-closure glaucoma group (r=-0.085; p=0.65), the open-angle glaucoma group (r=-0.070; p=0.69) and the normal eyes group (r=-0.120; p=0.52).
Conclusions:
The results of this assay suggest that there is no correlation between the central corneal thickness and the axial length in patients with glaucoma and individuals with normal eyes.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment